Healthcare Global Enterprises financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹695cr+13.4% on Q1 FY26
Net profit
₹16.5cr+175.3% on Q1 FY26
EBITDA margin
17.6%0.0 pts on Q1 FY26
EPS
₹0.92+170.6% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue695613+13.4%
EBITDA122108+13.4%
EBITDA margin17.6%17.6%0.0 pts
Profit before tax24.111.2+114.4%
Net profit16.56.0+175.3%
EPS₹0.92₹0.34+170.6%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹695 crNet profit₹16.5 crNet margin2.4%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
8,427————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
536536236273175
78.278.267.639.38.9
9109101,002673399
8,879————
2,6272,5452,2231,9121,694
—+14.5%+16.3%+12.8%—
480466387330299
18.3%18.3%17.4%17.2%17.6%
224222176155135
33.322.848.841.317.6
1.3%0.9%2.2%2.2%1.0%
₹1.58₹0.96₹3.09₹3.35₹2.04
—−69.0%−7.7%+64.1%—
—347317285252
—−292−209−186−133
55.055.010898.9118
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HCG₹585.60

Healthcare Global Enterprises Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹8,427 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————8,426.8
- Cash, Equiv & ST Investments174.6272.6235.9536.1536.1
+ Minority Interest8.939.367.678.278.2
+ Total Debt399.3672.81,002.2910.4910.4
Enterprise Value————8,879.4
Revenue1,694.41,912.12,222.92,545.42,627.4
Growth %, YoY—+12.8+16.3+14.5—
EBITDA298.7329.6387.3465.8480.3
Margin %17.6317.2417.4218.3018.28
EBIT135.2155.2175.9221.6223.6
Net Income17.641.348.822.833.3
Margin %1.042.162.200.891.27
EPS, Adj (current shares)2.043.353.090.961.58
Growth %, YoY—+64.1-7.7-69.0—
Cash from Operations251.6284.6317.1347.1—
Capital Expenditures-133.2-185.7-208.9-292.1—
Free Cash Flow118.498.9108.355.055.0
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Healthcare Global Enterprises financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Healthcare Global Enterprises (NSE: HCG) had a market capitalisation of ₹8,830 crore at the 29 October 2026 close (₹591.45 a share), a PE ratio of 387.6 on the last four quarters' profit and a price-to-book ratio of 6.63. In FY26 its consolidated net profit attributable to shareholders was ₹13.8 crore on revenue of ₹2,545 crore; in Q1 FY27 (April–June 2026) it was ₹13.8 crore, up 189.9% year on year. Its debt-to-equity ratio was 0.65 on 31 March 2026. Promoters held 64.21% of the shares on 30 September 2026.

Share price used
₹591.45 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Healthcare Global Enterprises at a glance · consolidated

Market cap
₹8,830 Crat ₹591.45 · 29 Oct close
PE ratio (last 4 quarters)
387.6641.7 on FY26 profit
Price to book (PB)
6.63book value ₹89.21 a share
ROE (FY26)
1.2%−3.9 pts vs FY25ROCE 8.2%
Debt to equity
0.65net debt ₹369 Cr
Promoter holding
64.21%unchanged vs 30 Jun 202630 September 2026
Net worth
₹1,332 Cr+44.4% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹55 Cr−49.2% vs FY25
EPS (FY26)
₹0.97

Questions

What is the Healthcare Global Enterprises PE ratio today?

Healthcare Global Enterprises' PE ratio is 387.6 at the 29 October 2026 close (₹591.45 a share): a market capitalisation of ₹8,830 crore divided by consolidated net profit attributable to shareholders of ₹22.8 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹13.8 crore) it is 641.7. These four quarters include net exceptional items of −₹44.6 crore (one-off charges reported separately), so the ratio on recurring profit would differ.

What is the Healthcare Global Enterprises PB ratio (price to book value)?

Healthcare Global Enterprises' price-to-book (PB) ratio is 6.63 at the 29 October 2026 close: a market capitalisation of ₹8,830 crore divided by shareholders' equity (book value) of ₹1,332 crore on 31 March 2026. That is a book value of ₹89.21 per share against a share price of ₹591.45.

What is the Healthcare Global Enterprises ROE and ROCE?

In FY26, Healthcare Global Enterprises' return on equity (ROE) was 1.2% and its return on capital employed (ROCE) was 8.2%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 5.1% and ROCE 7.9%.

What is the Healthcare Global Enterprises market cap?

Healthcare Global Enterprises' market capitalisation was ₹8,830 crore at the 29 October 2026 close: 14.93 crore shares at ₹591.45 each.

Is Healthcare Global Enterprises debt free?

No. Healthcare Global Enterprises had borrowings of ₹910 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.65. Its cash and current investments were ₹541 crore, so its net debt was ₹369 crore.

What is the Healthcare Global Enterprises EPS?

Healthcare Global Enterprises' basic earnings per share (EPS) were ₹0.97 in FY26, against ₹3.19 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹1.55.

What is the Healthcare Global Enterprises debt to equity ratio?

Healthcare Global Enterprises' debt-to-equity ratio was 0.65 on 31 March 2026: borrowings of ₹910 crore against total equity of ₹1,410 crore. A year earlier, on 31 March 2025, it was 1.01.

What is the Healthcare Global Enterprises book value per share?

Healthcare Global Enterprises' book value per share was ₹89.21 on 31 March 2026: shareholders' equity of ₹1,332 crore divided by the 14.93 crore shares in issue, up 34.8% from ₹66.17 a year earlier. The share price at the 29 October 2026 close was ₹591.45.

When are the Healthcare Global Enterprises next results?

Healthcare Global Enterprises will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, the date of the board meeting it has notified to the exchanges.

What is the Healthcare Global Enterprises net worth?

Healthcare Global Enterprises' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,332 crore on 31 March 2026, up 44.4% from ₹922 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹8,830 crore at the 29 October 2026 close.

What is the Healthcare Global Enterprises promoter holding?

Promoters held 64.21% of Healthcare Global Enterprises on 30 September 2026, unchanged from the previous quarter and up 0.43 percentage points from 63.78% a year earlier, according to the shareholding pattern filed with NSE.

What is the Healthcare Global Enterprises revenue and profit in FY26?

In FY26 (April 2025–March 2026), Healthcare Global Enterprises' consolidated net profit attributable to shareholders was ₹13.8 crore, down 69.0% from ₹44.4 crore in FY25, on revenue from operations of ₹2,545 crore (up 14.5%). Over three years, from FY23, net profit was down 53.1%.

What is the Healthcare Global Enterprises shareholding pattern?

On 30 September 2026, Healthcare Global Enterprises' shares were held by promoters 64.21%, foreign portfolio investors (FII/FPI) 2.69%, domestic institutions (DII) 20.77% (including mutual funds at 18.73%) and retail and other non-institutional investors 12.32%. Over the year, FII holding was down 0.90 percentage points from 3.59% and DII holding was up 2.41 percentage points from 18.36%.

What is the Healthcare Global Enterprises free cash flow?

In FY26, Healthcare Global Enterprises generated ₹347 crore of cash from operations and spent ₹292 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹55 crore. In FY25 it was ₹108 crore.

How does the Healthcare Global Enterprises PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Healthcare Global Enterprises' PE ratio is 641.7, the highest of the four: Apollo Hospitals Enterprise 60.7, Fortis Healthcare 54.7 and Rainbow Childrens Medicare 43.7, a peer average of 53.0. Each is the company's market capitalisation at that price divided by its FY26 net profit.

What are the Healthcare Global Enterprises latest quarterly results?

Healthcare Global Enterprises' latest results are for Q1 FY27 (April–June 2026), filed on 6 August 2026: consolidated net profit attributable to shareholders ₹13.8 crore, up 189.9% from ₹4.8 crore in Q1 FY26; revenue from operations ₹695 crore, up 13.4% year on year.

How does Healthcare Global Enterprises compare with its peers?

On FY26 consolidated figures, against Apollo Hospitals Enterprise, Fortis Healthcare and Rainbow Childrens Medicare: Healthcare Global Enterprises' operating margin of 8.7% is the lowest of the four (Apollo Hospitals Enterprise 11.5%, Fortis Healthcare 17.9%, Rainbow Childrens Medicare 23.1%; peer average 17.5%); its return on equity of 1.2% is the lowest of the four (Apollo Hospitals Enterprise 22.0%, Fortis Healthcare 11.1%, Rainbow Childrens Medicare 17.9%; peer average 17.0%); its revenue growth over three years of 14.5% a year is the second highest of the four (Apollo Hospitals Enterprise 14.9% a year, Fortis Healthcare 13.2% a year, Rainbow Childrens Medicare 13.2% a year; peer average 13.8% a year).

Healthcare Global Enterprises vs Apollo Hospitals Enterprise: how do they compare?

In FY26, Healthcare Global Enterprises earned net profit attributable to shareholders of ₹13.8 crore on revenue of ₹2,545 crore, against ₹1,942 crore on ₹25,229 crore for Apollo Hospitals Enterprise. Healthcare Global Enterprises' operating margin was 8.7% (Apollo Hospitals Enterprise 11.5%) and its return on equity 1.2% (Apollo Hospitals Enterprise 22.0%). At the 29 October 2026 close, Healthcare Global Enterprises' market capitalisation was ₹8,830 crore against ₹1,17,916 crore for Apollo Hospitals Enterprise, and its PE ratio on FY26 profit 641.7 against 60.7.

Where do these Healthcare Global Enterprises figures come from?

From Healthcare Global Enterprises' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.